Matches in Nanopublications for { ?s ?p "DDI between Verapamil and Tamsulosin - Verapamil, a CYP3A4 inhibitor, may decrease the metabolism and clearance of Tamsulosin, a CYP3A4 substrate. Monitor for changes in therapeutic/adverse effects of Tamsulosin if Verapamil is initiated, discontinued, or dose changed. [drugbank_resource:DB00661_DB00706]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00661_DB00706 label "DDI between Verapamil and Tamsulosin - Verapamil, a CYP3A4 inhibitor, may decrease the metabolism and clearance of Tamsulosin, a CYP3A4 substrate. Monitor for changes in therapeutic/adverse effects of Tamsulosin if Verapamil is initiated, discontinued, or dose changed. [drugbank_resource:DB00661_DB00706]" assertion.